logo

IMVT

Immunovant·NASDAQ
--
--(--)
--
--(--)
4.98 / 10
Netural

Analyst sentiment is mixed but leaning positive: 50% Buy and 50% Neutral ratings from two institutions, with a historical weighted rating of 2.21. Fund-flow data show a good score of 7.75/10, though overall and block trends are negative—suggesting incremental buying despite macro-level caution. Together, the analyst and fund-flow picture indicates constructive participation but no overwhelming conviction, aligning with the stock's neutral overall rating.

FundamentalSentiment(4.98)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

0%

Buy

50%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-06
InstitutionWolfe Research
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for IMVT?
  • IMVT holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.98/10 (Netural).